Dr. Behrouz Salehian joined the City of Hope's Department of Diabetes in 2007 from the Department of Medicine at Charles R. Drew University. His research and clinical interests include Endocrine tumors including thyroid cancers, neuroendocrine tumors and pituitary tumor. He is co-director of Thyroid Cancer Program as well as director of Diabetes Cardiovascular Risk Reduction Program at City of Hope. He is board certified by the American Board of Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine and the Iranian Board of Internal Medicine. Dr. Salehian also received an NIH Fellowship Training Award for Fellowship in Endocrinology, Diabetes, and male reproductive endocrinology at Harbor-UCLA in 1994.